Skip to main content
Top
Published in: Surgical Endoscopy 9/2014

01-09-2014

Laparoscopic versus open gastric resection for larger than 5 cm primary gastric gastrointestinal stromal tumors (GIST): a size-matched comparison

Authors: Jianxian Lin, Changming Huang, Chaohui Zheng, Ping Li, Jianwei Xie, Jiabin Wang, Jun Lu

Published in: Surgical Endoscopy | Issue 9/2014

Login to get access

Abstract

Background

Laparoscopic resection of gastric gastrointestinal stromal tumors (GISTs) appears technically feasible and associated with favorable outcomes. Tumor size plays an important role in surgical approach, with laparotomy tending to be used to treat larger tumors. This study evaluated the technical feasibility, safety, and oncologic efficacy of laparoscopic surgery for GISTs ≥5 cm in diameter.

Methods

One hundred forty patients who underwent resection of primary gastric GIST at our institution from January 2007 to December 2012 were identified. Twenty-three patients with tumor larger than 5 cm in diameter treated by laparoscopic resection and were randomly matched (1:1) by tumor size (±1 cm) to patients with open resection. Clinical and pathologic variables and surgical outcomes for each surgical type were identified and compared.

Results

There were no significant differences in clinicopathologic characteristics between the two groups. Laparoscopic group was superior to open group in operation time, blood loss, time to ground activities, time to first flatus, times to liquid diet, and postoperative stay (P < 0.05). Number of transfusions and time to semi-liquid diet, however, did not differ between groups. There was no operative mortality, and the postoperative complications were similar. Fifteen patients in the laparoscopic group and 17 patients in the open group received adjuvant treatment with imatinib. Recurrence or metastasis occurred in eight cases (three in the laparoscopic group and five in the open group). No significant difference in long-term disease-free survival was found between the two groups (P > 0.05).

Conclusion

When performed by experienced surgeons, laparoscopic resection for gastric GISTs larger than 5 cm is a safe and effective minimally invasive surgery.
Literature
1.
go back to reference Miettinen M, Lasota J (2001) Gastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438(1):1–12PubMedCrossRef Miettinen M, Lasota J (2001) Gastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438(1):1–12PubMedCrossRef
2.
go back to reference Corless CL, Fletcher JA, Heinrich MC (2004) Biology of gastrointestinal stromal tumors. J Clin Oncol 22(18):3813–3825PubMedCrossRef Corless CL, Fletcher JA, Heinrich MC (2004) Biology of gastrointestinal stromal tumors. J Clin Oncol 22(18):3813–3825PubMedCrossRef
3.
go back to reference DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231(1):51–58PubMedCentralPubMedCrossRef DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231(1):51–58PubMedCentralPubMedCrossRef
4.
go back to reference Woodall CE, Brock GN, Fan J, Byam JA, Scoggins CR, McMasters KM, Martin RC (2009) An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg 144(7):670–678PubMedCrossRef Woodall CE, Brock GN, Fan J, Byam JA, Scoggins CR, McMasters KM, Martin RC (2009) An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg 144(7):670–678PubMedCrossRef
6.
go back to reference Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC, Joensuu H, Le Cesne A, McClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD (2005) Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol 16(4):566–578PubMedCrossRef Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC, Joensuu H, Le Cesne A, McClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD (2005) Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol 16(4):566–578PubMedCrossRef
7.
go back to reference Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39(10):1411–1419PubMedCrossRef Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39(10):1411–1419PubMedCrossRef
8.
go back to reference Basu S, Balaji S, Bennett DH, Davies N (2007) Gastrointestinal stromal tumors (GIST) and laparoscopic resection. Surg Endosc 21(10):1685–1689PubMedCrossRef Basu S, Balaji S, Bennett DH, Davies N (2007) Gastrointestinal stromal tumors (GIST) and laparoscopic resection. Surg Endosc 21(10):1685–1689PubMedCrossRef
9.
10.
go back to reference Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M, Pappo AS, Pisters PW, Raut CP, Reichardt P, Tyler DS, Van den Abbeele AD, von Mehren M, Wayne JD, Zalcberg J (2007) NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5(2):1–29 Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M, Pappo AS, Pisters PW, Raut CP, Reichardt P, Tyler DS, Van den Abbeele AD, von Mehren M, Wayne JD, Zalcberg J (2007) NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5(2):1–29
11.
go back to reference Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY (2009) ESMO Guidelines Working Group. Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 4:64–67 Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY (2009) ESMO Guidelines Working Group. Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 4:64–67
12.
go back to reference Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39(10):1411–1419PubMedCrossRef Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39(10):1411–1419PubMedCrossRef
13.
go back to reference Matthews BD, Joels CS, Kercher KW, Heniford BT (2004) Gastrointestinal stromal tumors of the stomach. Minerva Chir 59(3):219–231PubMed Matthews BD, Joels CS, Kercher KW, Heniford BT (2004) Gastrointestinal stromal tumors of the stomach. Minerva Chir 59(3):219–231PubMed
14.
go back to reference Selcukbiricik F, Yalçın S, Tural D, Erdamar S, Demir G, Doğusoy G, Mandel NM (2013) Gastrointestinal stromal tumors in Turkey: experiences from three centers. Onkologie 36(1–2):18–24PubMedCrossRef Selcukbiricik F, Yalçın S, Tural D, Erdamar S, Demir G, Doğusoy G, Mandel NM (2013) Gastrointestinal stromal tumors in Turkey: experiences from three centers. Onkologie 36(1–2):18–24PubMedCrossRef
15.
go back to reference Blanke CD, Corless CL (2005) State-of-the art therapy for gastrointestinal stromal tumors. Cancer Invest 23(3):274–280PubMedCrossRef Blanke CD, Corless CL (2005) State-of-the art therapy for gastrointestinal stromal tumors. Cancer Invest 23(3):274–280PubMedCrossRef
16.
go back to reference Mochizuki Y, Kodera Y, Fujiwara M, Ito S, Yamamura Y, Sawaki A, Yamao K, Kato T (2006) Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experience. Surg Today 36(4):341–347PubMedCrossRef Mochizuki Y, Kodera Y, Fujiwara M, Ito S, Yamamura Y, Sawaki A, Yamao K, Kato T (2006) Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experience. Surg Today 36(4):341–347PubMedCrossRef
17.
go back to reference Daigle C, Meneghetti AT, Lam J, Panton ON (2012) Laparoscopic management of gastrointestinal stromal tumours: review at a Canadian centre. Can J Surg 55(2):105–109PubMedCentralPubMedCrossRef Daigle C, Meneghetti AT, Lam J, Panton ON (2012) Laparoscopic management of gastrointestinal stromal tumours: review at a Canadian centre. Can J Surg 55(2):105–109PubMedCentralPubMedCrossRef
18.
go back to reference Ma JJ, Hu WG, Zang L, Yan XW, Lu AG, Wang ML, Li JW, Feng B, Zhong J, Zheng MH (2011) Laparoscopic gastric resection approaches for gastrointestinal stromal tumors of stomach. Surg Laparosc Endosc Percutan Tech 21(2):101–105PubMedCrossRef Ma JJ, Hu WG, Zang L, Yan XW, Lu AG, Wang ML, Li JW, Feng B, Zhong J, Zheng MH (2011) Laparoscopic gastric resection approaches for gastrointestinal stromal tumors of stomach. Surg Laparosc Endosc Percutan Tech 21(2):101–105PubMedCrossRef
19.
go back to reference Pitsinis V, Khan AZ, Cranshaw I, Allum WH (2007) Singlecenter experience of laparoscopic versus open resection for gastrointestinal stromal tumors of the stomach. Hepatogastroenterology 54(74):606–608PubMed Pitsinis V, Khan AZ, Cranshaw I, Allum WH (2007) Singlecenter experience of laparoscopic versus open resection for gastrointestinal stromal tumors of the stomach. Hepatogastroenterology 54(74):606–608PubMed
20.
go back to reference Chen YH, Liu KH, Yeh CN, Hsu JT, Liu YY, Tsai CY, Chiu CT, Jan YY, Yeh TS (2012) Laparoscopic resection of gastrointestinal stromal tumors: safe, efficient, and comparable oncologic outcomes. J Laparoendosc Adv Surg Tech A 22(8):758–763PubMedCrossRef Chen YH, Liu KH, Yeh CN, Hsu JT, Liu YY, Tsai CY, Chiu CT, Jan YY, Yeh TS (2012) Laparoscopic resection of gastrointestinal stromal tumors: safe, efficient, and comparable oncologic outcomes. J Laparoendosc Adv Surg Tech A 22(8):758–763PubMedCrossRef
21.
go back to reference Novitsky YW, Kercher KW, Sing RF, Heniford BT (2006) Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg 243(6):738–745PubMedCentralPubMedCrossRef Novitsky YW, Kercher KW, Sing RF, Heniford BT (2006) Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg 243(6):738–745PubMedCentralPubMedCrossRef
22.
go back to reference Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, De-Matteo RP, Strong VE (2011) Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol 18(6):1599–1605PubMedCrossRef Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, De-Matteo RP, Strong VE (2011) Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol 18(6):1599–1605PubMedCrossRef
23.
go back to reference Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P (2012) Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 13(3):265–274PubMedCrossRef Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P (2012) Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 13(3):265–274PubMedCrossRef
24.
go back to reference Nowain A, Bhakta H, Pais S, Kanel G, Verma S (2005) Gastrointestinal stromal tumors: clinical profile, pathogenesis, treatment strategies and prognosis. J Gastroenterol Hepatol 20(6):818–824PubMedCrossRef Nowain A, Bhakta H, Pais S, Kanel G, Verma S (2005) Gastrointestinal stromal tumors: clinical profile, pathogenesis, treatment strategies and prognosis. J Gastroenterol Hepatol 20(6):818–824PubMedCrossRef
25.
go back to reference Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T (2003) Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 6(1):39–48PubMedCrossRef Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T (2003) Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 6(1):39–48PubMedCrossRef
26.
go back to reference Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, Roberts P, Demetri G (2002) Management of malignant gastrointestinal stromal tumours. Lancet Oncol 3(11):655–664PubMedCrossRef Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, Roberts P, Demetri G (2002) Management of malignant gastrointestinal stromal tumours. Lancet Oncol 3(11):655–664PubMedCrossRef
27.
go back to reference Reece-Smith AM, MacGoey P, Shah MA, Leeder P, Andrew DR, McCulloch T, Parsons SL (2012) A multi-centre analysis of the impact of updated risk stratification on follow-up of gastric gastro-intestinal stromal tumours in the post-imatinib era. Eur J Surg Oncol 38(6):484–489PubMedCrossRef Reece-Smith AM, MacGoey P, Shah MA, Leeder P, Andrew DR, McCulloch T, Parsons SL (2012) A multi-centre analysis of the impact of updated risk stratification on follow-up of gastric gastro-intestinal stromal tumours in the post-imatinib era. Eur J Surg Oncol 38(6):484–489PubMedCrossRef
28.
go back to reference Eisenberg BL, Harris J, Blanke CD, Demetri GD, Heinrich MC, Watson JC, Hoffman JP, Okuno S, Kane JM, von Mehren M (2009) Phase II trial of neoadjuvant/ adjuvant imatinib mesylate (IM) for advanced primary and metastatic/ recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol 99(1):42–47PubMedCentralPubMedCrossRef Eisenberg BL, Harris J, Blanke CD, Demetri GD, Heinrich MC, Watson JC, Hoffman JP, Okuno S, Kane JM, von Mehren M (2009) Phase II trial of neoadjuvant/ adjuvant imatinib mesylate (IM) for advanced primary and metastatic/ recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol 99(1):42–47PubMedCentralPubMedCrossRef
29.
go back to reference Blesius A, Cassier PA, Bertucci F, Fayette J, Ray-Coquard I, Bui B, Adenis A, Rios M, Cupissol D, Perol D, Blay JY, Le Cesne A (2011) Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial. BMC Cancer 11:72PubMedCentralPubMedCrossRef Blesius A, Cassier PA, Bertucci F, Fayette J, Ray-Coquard I, Bui B, Adenis A, Rios M, Cupissol D, Perol D, Blay JY, Le Cesne A (2011) Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial. BMC Cancer 11:72PubMedCentralPubMedCrossRef
30.
go back to reference Kodera Y, Fujiwara M, Ohashi N, Nakayama G, Koike M, Morita S, Nakao A (2010) Laparoscopic surgery for gastric cancer: a collective review with meta-analysis of randomized trials. J Am Coll Surg 211(5):677–686PubMedCrossRef Kodera Y, Fujiwara M, Ohashi N, Nakayama G, Koike M, Morita S, Nakao A (2010) Laparoscopic surgery for gastric cancer: a collective review with meta-analysis of randomized trials. J Am Coll Surg 211(5):677–686PubMedCrossRef
31.
go back to reference Feng B, Sun J, Ling TL, Lu AG, Wang ML, Chen XY, Ma JJ, Li JW, Zang L, Han DP, Zheng MH (2012) Laparoscopic complete mesocolic excision (CME) with medial access for right-hemi colon cancer: feasibility and technical strategies. Surg Endosc 26(12):3669–3675PubMedCrossRef Feng B, Sun J, Ling TL, Lu AG, Wang ML, Chen XY, Ma JJ, Li JW, Zang L, Han DP, Zheng MH (2012) Laparoscopic complete mesocolic excision (CME) with medial access for right-hemi colon cancer: feasibility and technical strategies. Surg Endosc 26(12):3669–3675PubMedCrossRef
32.
go back to reference Bagshaw PF, Allardyce RA, Frampton CM, Frizelle FA, Hewett PJ, McMurrick PJ, Rieger NA, Smith JS, Solomon MJ, Stevenson AR (2012) Long-term outcomes of the Australasian Randomized Clinical Trial comparing laparoscopic and conventional open surgical treatments for colon cancer: the Australasian Laparoscopic Colon Cancer Study Trial. Ann Surg 256(6):915–919PubMedCrossRef Bagshaw PF, Allardyce RA, Frampton CM, Frizelle FA, Hewett PJ, McMurrick PJ, Rieger NA, Smith JS, Solomon MJ, Stevenson AR (2012) Long-term outcomes of the Australasian Randomized Clinical Trial comparing laparoscopic and conventional open surgical treatments for colon cancer: the Australasian Laparoscopic Colon Cancer Study Trial. Ann Surg 256(6):915–919PubMedCrossRef
Metadata
Title
Laparoscopic versus open gastric resection for larger than 5 cm primary gastric gastrointestinal stromal tumors (GIST): a size-matched comparison
Authors
Jianxian Lin
Changming Huang
Chaohui Zheng
Ping Li
Jianwei Xie
Jiabin Wang
Jun Lu
Publication date
01-09-2014
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 9/2014
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-014-3506-x

Other articles of this Issue 9/2014

Surgical Endoscopy 9/2014 Go to the issue